U.S. stocks pared early losses on Wednesday but remained mostly lower after inflation data came in hotter than expected, potentially complicating the Federal Reserve's job of returning inflation to ...
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...
Enbridge and Brookfield Asset Management are exceptional long-term high-yield investments. Read how these can help investors ...
Investors have watched Wall Street's major market averages fall on Wednesday while yields jumped in response to the latest ...
2-Year U.S. Treasury Note Continuous Contract $102.551-0.148-0.14% 5-Year U.S. Treasury Note Continuous Contract $105.875-0.453-0.43% 10-Year U.S. Treasury Note Continuous Contract $108.250-0.703 ...
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for priority review with a PDUFA date of July 22, 2025 ...
Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein ...
When a stock breaks out of a well-formed base, you normally want to see the Relative Strength Rating exceed 80.
Net income of $0.8 millionAdjusted EBITDA1 of $1.3 millionPediatric Portfolio net revenue up 86% sequentiallyFirst quarterly sequential prescription increase for both ADHD and Pediatric portfolios sin ...
KALMAR CORPORATION, FINANCIAL STATEMENTS REVIEW 2024, 13 FEBRUARY 2025 AT 9:00 AM (EET) Kalmar's financial statements review January-December 2024: Resilient profitability and strong orders in the ...
EB5 Capital, a leading Regional Center operator in the EB-5 industry, announced today that it has received a partial $12.38 ...
The Handmaid’s Tale will release its sixth and final season in April. The final chapter follows Elisabeth Moss’ June Osborne ...